Editorial

od PEAKMAN, MARK
Izdano 2006

Can we vaccinate against Type 1 diabetes?

od Peakman, Mark
Izdano 2012

Basic and clinical immunology /

od Peakman, Mark, Vergani, Diego
Izdano 2009

Immunology

od Kemeny, Mike, Peakman, Mark
Izdano 1998

Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?

od Peakman, Mark, Dayan, Colin M
Izdano 2001

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

od Peakman, Mark, von Herrath, Matthias
Izdano 2010

Antigen Targets of Type 1 Diabetes Autoimmunity

od Roep, Bart O., Peakman, Mark
Izdano 2012

Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances

od Smith, Emma L., Peakman, Mark
Izdano u Front Immunol (2018)

Immunological dysfunction, vaccination and Gulf War illness

od Peakman, Mark, Skowera, Ania, Hotopf, Matthew
Izdano 2006

In silico and ex vivo approaches indicate immune pressure on capsid and non-capsid regions of coxsackie B viruses in the human system

od Kundu, Rhiannon, Knight, Robin, Dunga, Meenakshi, Peakman, Mark
Izdano u PLoS One (2018)

Identification of a Naturally Processed Cytotoxic CD8 T-Cell Epitope of Coxsackievirus B4, Presented by HLA-A2.1 and Located in the PEVKEK Region of the P2C Nonstructural Protein

od Varela-Calvino, Ruben, Skowera, Ania, Arif, Sefina, Peakman, Mark
Izdano 2004

Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it?

od Hull, Caroline M., Peakman, Mark, Tree, Timothy I. M.
Izdano u Diabetologia (2017)

T cell receptor β-chains display abnormal shortening and repertoire sharing in type 1 diabetes

od Gomez-Tourino, Iria, Kamra, Yogesh, Baptista, Roman, Lorenc, Anna, Peakman, Mark
Izdano u Nat Commun (2017)

HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides

od Ellis, Richard J, Varela-Calvino, Ruben, Tree, Timothy I M, Peakman, Mark
Izdano 2005

Proinsulin-mediated induction of type 1 diabetes in HLA-DR4-transgenic mice

od Verhagen, Johan, Smith, Emma L., Whettlock, Emily M., Macintyre, Benedict, Peakman, Mark
Izdano u Sci Rep (2018)

The challenge of modulating β-cell autoimmunity in type 1 diabetes

od Atkinson, Mark A., Roep, Bart O., Posgai, Amanda, Wheeler, Daniel C.S., Peakman, Mark
Izdano u Lancet Diabetes Endocrinol (2018)

Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial–Type 1 (DPT-1) oral insulin trial

od Vehik, Kendra, Cuthbertson, David, Ruhlig, Holly, Schatz, Desmond A., Peakman, Mark, Krischer, Jeffrey P.
Izdano 2011

CO-STIMULATION BLOCKADE DISRUPTS CD4(+) T-CELL MEMORY PATHWAYS AND UNCOUPLES THEIR LINK TO DECLINE IN β-CELL FUNCTION IN TYPE 1 DIABETES

od Eichmann, Martin, Baptista, Roman, Ellis, Richard J., Heck, Susanne, Peakman, Mark, Beam, Craig A.
Izdano u J Immunol (2020)

Variation of Peripheral Blood Mononuclear Cell RNA Quality in Archived Samples

od Kozlakidis, Zisis, Mant, Christine, Abdinur, Fartun, Cope, Andrew, Steiner, Szabi, Peakman, Mark, Hayday, Adrian, Cason, John
Izdano 2011

What does it take to be healthy? Investigating immune-deficiency in non-immunodeficient scenarios

od Binda, Elisa, Schulz, Reiner, Showera, Ania, Cope, Andrew, Malim, Michael, Cason, John, Peakman, Mark, Hayday, Adrian
Izdano 2012